Bayer Healthcare announced on Monday it "has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO," according to a Bayer press release. The WHO will provide the antibiotics to China's national TB program through the Stop TB Partnership's Global Drug Facility, the release states (8/15).